» Articles » PMID: 21931380

Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells

Overview
Specialty Gastroenterology
Date 2011 Sep 21
PMID 21931380
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Recent evidence suggests a role for increased colonic permeability and mucosal mast cell (MC) mediators on symptoms related to the irritable bowel syndrome (IBS). Whether allergic factors (AFs) are involved in the pathophysiology of IBS is unclear. We addressed the question of the possible influence of an allergic background on IBS symptoms.

Methods: We assessed paracellular permeability, mucosal MCs counts, and spontaneous release of tryptase of colonic biopsy specimens in 34 IBS patients and 15 healthy subjects. The severity of IBS was assessed through self-reported questionnaires. All individuals were tested for the presence of AF, including self-perception of adverse reaction to food, personal and familial history of atopic disease, elevated total or specific immunoglobulin E against food/inhalant antigens, blood eosinophilia, and skin tests.

Results: IBS patients had significant enhanced colonic permeability, higher number of MCs, and spontaneous release of tryptase than healthy subjects. The severity of IBS was significantly correlated with colonic permeability (r=0.48, P=0.004), MCs counts (r=0.36, P=0.03), and tryptase (r=0.48, P=0.01). In 13 IBS patients (38.2%) having at least three AFs, symptoms scores, colonic permeability, MCs counts, and tryptase release by colonic biopsies were significantly higher than in those with less than three AFs. IBS patients with at least three AFs were more prone to diarrhea or alternating symptoms. None AF was found to be predictive of IBS severity.

Conclusions: In IBS patients, the presence of an allergic background correlates with a more severe disease and diarrhea predominance, possibly by enhancing mucosal MC activation and paracellular permeability.

Citing Articles

Evidence-Based Clinical Guidelines for Chronic Diarrhea 2023.

Ihara E, Manabe N, Ohkubo H, Ogasawara N, Ogino H, Kakimoto K Digestion. 2024; 105(6):480-497.

PMID: 39197422 PMC: 11633876. DOI: 10.1159/000541121.


Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).

Lacy B, Rosenbaum D, Edelstein S, Kozuka K, Williams L, Kunkel D Clin Exp Gastroenterol. 2024; 17:173-183.

PMID: 38860153 PMC: 11164200. DOI: 10.2147/CEG.S455101.


Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders.

Brankovic M, Gmizic T, Dukic M, Zdravkovic M, Daskalovic B, Mrda D Antioxidants (Basel). 2024; 13(5).

PMID: 38790705 PMC: 11117950. DOI: 10.3390/antiox13050600.


NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.

King A, Chang L, Li Q, Liu L, Zhu Y, Pasricha P Am J Physiol Gastrointest Liver Physiol. 2024; 326(5):G543-G554.

PMID: 38252683 PMC: 11376972. DOI: 10.1152/ajpgi.00233.2023.


Soybean glycinin and β-conglycinin damage the intestinal barrier by triggering oxidative stress and inflammatory response in weaned piglets.

Wang L, Li W, Xin S, Wu S, Peng C, Ding H Eur J Nutr. 2023; 62(7):2841-2854.

PMID: 37358571 DOI: 10.1007/s00394-023-03188-8.